2021-11-16-世界卫生组织-Cervical_cancer_Kuwait_2021_country_profile_1页_64kb

Kuwait Cervical Cancer Profile Summary

Morbidity and Mortality

• Crude cervical cancer incidence per 100,000 women in 2020: 3.2
• Age-standardized cervical cancer incidence per 100,000 women in 2020: 2.8 (cumulative risk data not specified)
• Cervical cancer deaths in 2019: 2,000 among a female population of 1,644,000
• Mortality-to-incidence ratio in 2020: 0.53
• Population-based cancer registry available (last assessed 2021)

Primary Prevention: HPV Vaccination

• HPV not included in national vaccination program
• Vaccination coverage among 9-14-year-old girls: under 10% (details not available for specific doses or targets)
• Year of introduction: approximately 2020 (incomplete details)
• Primary target cohort: girls aged 9-14, but low coverage

Secondary Prevention: Screening

• National cervical cancer screening program exists (noted in 2021)
• Primary screening test: data not specified, but focuses on high-risk groups
• Target age range for screening: not detailed in 2021 guidelines
• Early detection in primary healthcare: possible, but implementation unclear (data noted as "Yes" but not fully defined)
• Referral system from primary to secondary/tertiary care: available (indicated as "Yes") but likely limited in effectiveness
• Ever screened (women aged 30-49): 16%, and 32% screened in the last 5 years

Treatment and Supportive Care

• National guidelines on cervical cancer management exist (as of 2021)
• Radiotherapy units: 223 per 10,000 cancer patients
• Cancer diagnosis and treatment services: generally available (details sparse)
• Tertiary cancer centers: not specified
• Healthcare staff and specialists (e.g., surgeons, oncologists): availability data incomplete (some ND or unknown)

WHO Cervical Cancer Elimination Strategy Context

• Country profile date: 2021 report
• Key indicators: Low program coverage for prevention/s screening, lack of full coordination despite on-paper guidelines; significant disease burden noted